Efficacy and safety of nintedanib (NIN)/docetaxel (DOC) in patients with lung adenocarcinoma: further analyses from the LUME-Lung 1 study.
Heigener, D Gottfried, M Bennouna, J Bondarenko, I Douillard, J Krzakowski, M Mellemgaard, A Novello, S Orlov, S Summers, Yvonne J
Heigener, D
Gottfried, M
Bennouna, J
Bondarenko, I
Douillard, J
Krzakowski, M
Mellemgaard, A
Novello, S
Orlov, S
Summers, Yvonne J
Citations
Altmetric:
Abstract
Description
Date
2016-10-01
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Efficacy and safety of nintedanib (NIN)/docetaxel (DOC) in patients with lung adenocarcinoma: further analyses from the LUME-Lung 1 study. 2016, 27(suppl 6):1276P Annals of Oncology